JP

About Jaroline Pharma

Jaroline Pharma is a private limited company (BV/SRL) based in Fosses-la-Ville, founded in 2025. For the 2025 financial year, Jaroline Pharma reported a loss of €1,387. Revenue was not published, which is common for abbreviated accounts. The gross margin came to -€915. Equity stands at €3,613, a solvency ratio of 0.6%.

Juridical situation
Normal situation
Company number
1023.796.101
Founding date
Founded on 28-05-2025
EUID number
BEKBOBCE.1023.796.101
Type of enterprise
Rechtspersoon
Location
Rue Rauhisse, Vitrival 47 Fosses-La-Ville 5070
Juridical form
BV — Private limited company (BV/SRL)
Signals
Reporting losses
Poor liquidity
Negative cashflow
Negative EBITDA

Financial ratios

Profit
€ -1K
Equity
€ 4K
Gross margin
€ -915
Health
Solvability > 25%
0.6%
Liquidity > 1.0
0.01
Profitability > 0%
-38.4%
2025
Gross margin
€ -915
EBITDA
€ -1K
Profit
€ -1K
Equity
€ 4K
Solvability
0.62%
Debt
€ 581K
Cash
€ 4K

Frequently asked questions

Answers to the most common questions about Jaroline Pharma, based on official government data and the filed annual accounts.

What is the VAT number of Jaroline Pharma?

The VAT number of Jaroline Pharma is BE1023.796.101.

When was Jaroline Pharma established?

Jaroline Pharma was founded in 28-05-2025.

What is the official address of Jaroline Pharma?

The official address of Jaroline Pharma is Rue Rauhisse, Vitrival 47 Fosses-La-Ville 5070.

What is the legal form of Jaroline Pharma?

The juridical form of Jaroline Pharma is Private limited company (BV/SRL).

What is the annual revenue of Jaroline Pharma?

The 2025 accounts of Jaroline Pharma do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.

Is Jaroline Pharma a reliable company?

Jaroline Pharma is a registered Rechtspersoon with company number 1023.796.101 and can be verified through the official CBE database.

What is the credit limit of Jaroline Pharma?

The estimated credit limit of Jaroline Pharma is €127.

Is Jaroline Pharma still active?

Jaroline Pharma currently has the status "Normal situation" and is active.

Further reading

View all insights

Sources